Skip to content
Fiscal Receipts

Senate LDA lobbying filing

MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER

Registrant: NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC Year: 2025 Period: Third Quarter Type: Q3

View on lda.senate.gov ↗

Reported income

$30.0K

Reported expenses

not reported

Tracked program mentions1

Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.

  • Emergency Management Modernization Program9666BU8000matched: “Emergency|Modernizationmatched 2+ title words

    H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician…

Lobbying activities4

  • Health IssuesHCR

    H.R. 3521, Clinical Trial Modernization Act; H.R. 1, One Big Beautiful Bill (Definition clarity around distributors); Drug Shortages; Safe Step Act (not reintroduced in 119th) (Support establishing an exception to medication step-therapy protocol in specified cases).

  • ManufacturingMAN

    H.R. 2444, Promoting Resilient Supply Chains Act; S. 257, Promoting Resilient Supply Chains

  • Medicare/MedicaidMMM

    H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness.

  • PharmacyPHA

    H.R. 3164, Ensuring Community Access to Pharmacist Services Act

Lobbyists3

  • ERIC SILVA
  • ERIC SILVArevolving door

    Legislative Aide, Senate EPW & Senator James Jeffords

  • REILLY O'CONNOR

Source: U.S. Senate Lobbying Disclosure Act database. Dollar figures (underlined) cite the filing record on lda.senate.gov — click to view the citation. Amounts shown as “not reported” are absent from the filing itself.